TEMIXYS Drug Patent Profile
✉ Email this page to a colleague
When do Temixys patents expire, and when can generic versions of Temixys launch?
Temixys is a drug marketed by Chartwell Rx and is included in one NDA.
The generic ingredient in TEMIXYS is lamivudine; tenofovir disoproxil fumarate. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the lamivudine; tenofovir disoproxil fumarate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TEMIXYS?
- What are the global sales for TEMIXYS?
- What is Average Wholesale Price for TEMIXYS?
Summary for TEMIXYS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for TEMIXYS |
| What excipients (inactive ingredients) are in TEMIXYS? | TEMIXYS excipients list |
| DailyMed Link: | TEMIXYS at DailyMed |
US Patents and Regulatory Information for TEMIXYS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | TEMIXYS | lamivudine; tenofovir disoproxil fumarate | TABLET;ORAL | 211284-001 | Nov 16, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
